Interviews

Nov 15, 2017
Andrew Lane, EVP, Established Pharmaceuticals at Abbott, tells Pharm Exec how understanding emerging market dynamics can explain why branded generic medicines are important.
Nov 13, 2017
Mark Reisenauer, SVP, Oncology Business Unit at Astellas, tells PharmExec about the development and objectives of the Astellas Oncology C3 Prize.
Nov 12, 2017
Prognos CEO Sundeep Bhan talks about how the company’s unique offering will reach beyond life sciences as the long-promised benefits of AI become reality.
Oct 31, 2017
Ed Gudaitis Allergan VP and Country Manager, Canada, explains how embracing disruption is his secret to success.
Oct 19, 2017
Selecta Biosciences CEO Dr. Werner Cautreels talks about the company's innovative technology and how his entrepreneurial experiences in big pharma prepared him for the challenge of a new startup.
Oct 06, 2017
TESARO president and COO Mary Lynne Hedley talks about responsible drug development and commercialization, and the practical dimension of putting patients first.
Sep 06, 2017
Pharmaceutical Executive
Cynthia Schwalm, EVP and president of North American commercial operations for Ipsen, talks to Pharm Exec about the importance of stepping outside of the C-suite and into the world of the patient.
Aug 29, 2017
Pharmaceutical Executive
IFPMA's new Assistant Director General speaks about her mission to use the organization’s international reach to find real and practical solutions to the most pressing global healthcare challenges.
Aug 28, 2017
Everyone’s talking value, but not everyone is willing to pin down the elusive concept. Pharm Exec talks with Steven Pearson, founder of the Institute for Clinical Effectiveness Review (ICER), about all things value-based.
Aug 25, 2017
By Pharmaceutical Executive Editors
Edge Therapeutics’ Justin Zamirowski and EightSpokes’ Andy Mehrotra discuss how a new, collaborative approach to managing projects across the enterprise is improving time to market.
native1_300x100
lorem ipsum